US Congress House Bill 3520 (Prior Session Legislation)

---

Spectrum: Slight Partisan Bill (Republican 3-1)
Status: Introduced on June 26 2019 - 25% progression, died in committee
Action: 2019-06-27 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]

Modifies and reauthorizes through FY2024 the C.W. Bill Young Cell Transplantation Program, which provides support to patients who need a potentially life-saving bone marrow transplant or umbilical cord blood transplant. It also reauthorizes through FY2024 the Stem Cell Therapeutic and Research Act of 2005, which provides for the collection and maintenance of new units of high-quality cord blood. The bill requires the Advisory Council on Blood Stem Cell Transplantation to convene at least twice per calendar year.

Stem Cell Therapeutic and Research Reauthorization Act of 2019

Rep. Christopher Smith [R-NJ]

Rep. Gus Bilirakis [R-FL]

Rep. Cindy Axne [D-IA]

Rep. Blaine Luetkemeyer [R-MO]

Date	Chamber	Action
2019-06-27	House	Referred to the Subcommittee on Health.
2019-06-26	House	Referred to the House Committee on Energy and Commerce.
2019-06-26	House	Introduced in House

HB4764 (Related) 2020-12-14 - Message on Senate action sent to the House.
SB4672 (Related) 2020-09-23 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (Sponsor introductory remarks on measure: CR S5835)

Type	Source
Summary	https://www.congress.gov/bill/116th-congress/house-bill/3520/all-info
Text	https://www.congress.gov/116/bills/hr3520/BILLS-116hr3520ih.pdf